MedTrace Logo

Dietary Supplementation on Gastrointestinal Barrier Function

NCT06262880 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2024-03-08

No results posted yet for this study

Summary

The purpose of the current study is to examine the effects of a dietary supplement containing plant derived phenolics at two different dose levels on parameters of gastrointestinal (GI) health in otherwise generally healthy adults with risk factors (high BMI and waist circumference) for increased GI permeability. The primary hypothesis is that supplementation with plant derived phenolics will improve gut health compared to placebo.

Conditions

  • Intestinal Permeability

Interventions

DIETARY_SUPPLEMENT

plant derived phenolics

Dietary supplement containing plant derived phenolics

OTHER

Microcrystaline cellulose (MCC)

Placebo treatment: Microcrystaline cellulose

Sponsors & Collaborators

  • Brightseed

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-06
Primary Completion
2024-12-20
Completion
2025-02-06

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06262880 on ClinicalTrials.gov